Female predominance and X chromosome defects in autoimmune diseases

Journal of Autoimmunity

Volumn 33, Issue 1, 2009, Pages 12-16

  Invernizzi, Pietro ^a,c   Pasini, Simone ^a,b   Selmi, Carlo ^a,b,c   Gershwin, M Eric ^c   Podda, Mauro ^a,b  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimmune disease; Etiopathogenesis; Female preponderance; Genetic factors; Sex chromosomes

Indexed keywords

SEX HORMONE;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CHROMOSOME INACTIVATION; DIAGNOSTIC ACCURACY; FEMALE; GENE DOSAGE; GENETIC PREDISPOSITION; GENETIC TRAIT; HUMAN; LABORATORY DIAGNOSIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROCHIMERISM; MONOSOMY; MORBIDITY; MORTALITY; NONHUMAN; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; X CHROMOSOME ABERRATION;

AUTOIMMUNE DISEASES; CHIMERISM; CHROMOSOMES, HUMAN, X; FEMALE; FETAL DEVELOPMENT; GENE DOSAGE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MONOSOMY; PREGNANCY; SEX CHROMOSOME ABERRATIONS;

EID: 67349085696     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2009.03.005     Document Type: Review

References (62)

1. Rose N.R., and Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 14 (1993) 426-430
2. Jacobson D.L., Gange S.J., Rose N.R., and Graham N.M. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 84 (1997) 223-243
3. Eaton W.W., Rose N.R., Kalaydjian A., Pedersen M.G., and Mortensen P.B. Epidemiology of autoimmune diseases in Denmark. J Autoimmun 29 (2007) 1-9
4. Eidinger D., and Garrett T.J. Studies of the regulatory effects of the sex hormones on antibody formation and stem cell differentiation. J Exp Med 136 (1972) 1098-1116
5. Weinstein Y., Ran S., and Segal S. Sex-associated differences in the regulation of immune responses controlled by the MHC of the mouse. J Immunol 132 (1984) 656-661
6. McCluskey J., and Peh C.A. The human leucocyte antigens and clinical medicine: an overview. Rev Immunogenet 1 (1999) 3-20
7. Etzensperger R., McMahon R.M., Jones E.Y., and Fugger L. Dissection of the multiple sclerosis associated DR2 haplotype. J Autoimmun 31 (2008) 201-207
8. Baschal E.E., and Eisenbarth G.S. Extreme genetic risk for type 1A diabetes in the post-genome era. J Autoimmun 31 (2008) 1-6
9. Jacobson E.M., Huber A., and Tomer Y. The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J Autoimmun 30 (2008) 58-62
10. Carson D.A. Genetic factors in the etiology and pathogenesis of autoimmunity. FASEB J 6 (1992) 2800-2805
11. Jacobson E.M., and Tomer Y. The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future. J Autoimmun 28 (2007) 85-98
12. Castro J., Balada E., Ordi-Ros J., and Vilardell-Tarres M. The complex immunogenetic basis of systemic lupus erythematosus. Autoimmun Rev 7 (2008) 345-351
13. Li H.S., Ligons D.L., and Rose N.R. Genetic complexity of autoimmune myocarditis. Autoimmun Rev 7 (2008) 168-173
14. Sachidanandam R., Weissman D., Schmidt S.C., Kakol J.M., Stein L.D., Marth G., et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409 (2001) 928-933
15. Zandman-Goddard G., Peeva E., and Shoenfeld Y. Gender and autoimmunity. Autoimmun Rev 6 (2007) 366-372
16. Gleicher N., and Barad D.H. Gender as risk factor for autoimmune diseases. J Autoimmun 28 (2007) 1-6
17. Lleo A., Battezzati P.M., Selmi C., Gershwin M.E., and Podda M. Is autoimmunity a matter of sex?. Autoimmun Rev 7 (2008) 626-630
18. Cutolo M., Capellino S., Sulli A., Serioli B., Secchi M.E., Villaggio B., et al. Estrogens and autoimmune diseases. Ann N Y Acad Sci 1089 (2006) 538-547
19. Nelson J.L., Furst D.E., Maloney S., Gooley T., Evans P.C., Smith A., et al. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 351 (1998) 559-562
20. Artlett C.M., Smith J.B., and Jimenez S.A. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Engl J Med 338 (1998) 1186-1191
21. Ando T., Imaizumi M., Graves P.N., Unger P., and Davies T.F. Intrathyroidal fetal microchimerism in Graves' disease. J Clin Endocrinol Metab 87 (2002) 3315-3320
22. Srivatsa B., Srivatsa S., Johnson K.L., Samura O., Lee S.L., and Bianchi D.W. Microchimerism of presumed fetal origin in thyroid specimens from women: a case-control study. Lancet 358 (2001) 2034-2038
23. Corpechot C., Barbu V., Chazouilleres O., and Poupon R. Fetal microchimerism in primary biliary cirrhosis. J Hepatol 33 (2000) 696-700
24. Invernizzi P., De Andreis C., Sirchia S.M., Battezzati P.M., Zuin M., Rossella F., et al. Blood fetal microchimerism in primary biliary cirrhosis. Clin Exp Immunol 122 (2000) 418-422
25. Nomura K., Sumida Y., Yoh T., Morita A., Matsumoto Y., Taji S., et al. Lack of evidence for leukocyte maternal microchimerism in primary biliary cirrhosis. World J Gastroenterol 10 (2004) 2415-2416
26. Schoniger-Hekele M., Muller C., Ackermann J., Drach J., Wrba F., Penner E., et al. Lack of evidence for involvement of fetal microchimerism in pathogenesis of primary biliary cirrhosis. Dig Dis Sci 47 (2002) 1909-1914
27. Stevens A.M., Hermes H.M., Rutledge J.C., Buyon J.P., and Nelson J.L. Myocardial-tissue-specific phenotype of maternal microchimerism in neonatal lupus congenital heart block. Lancet 362 (2003) 1617-1623
28. Lyon M.F. Gene action in the X-chromosome of the mouse (Mus musculus L.). Nature 190 (1961) 372-373
29. Scofield R.H., Bruner G.R., Namjou B., Kimberly R.P., Ramsey-Goldman R., Petri M., et al. Klinefelter's syndrome (47,XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome. Arthritis Rheum 58 (2008) 2511-2517
30. Carneiro-Sampaio M., and Coutinho A. Tolerance and autoimmunity: lessons at the bedside of primary immunodeficiencies. Adv Immunol 95 (2007) 51-82
31. Powell B.R., Buist N.R., and Stenzel P. An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J Pediatr 100 (1982) 731-737
32. Gulino A.V., and Notarangelo L.D. Hyper IgM syndromes. Curr Opin Rheumatol 15 (2003) 422-429
33. Schurman S.H., and Candotti F. Autoimmunity in Wiskott-Aldrich syndrome. Curr Opin Rheumatol 15 (2003) 446-453
34. Derry J.M., Ochs H.D., and Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 78 (1994) 635-644
35. Doffinger R., Smahi A., Bessia C., Geissmann F., Feinberg J., Durandy A., et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet 27 (2001) 277-285
36. Noguchi M., Yi H., Rosenblatt H.M., Filipovich A.H., Adelstein S., Modi W.S., et al. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73 (1993) 147-157
37. Sawalha A.H., Webb R., Han S., Kelly J.A., Kaufman K.M., Kimberly R.P., et al. Common variants within MECP2 confer risk of systemic lupus erythematosus. PLoS One 3 (2008) e1727
38. Carrel L., and Willard H.F. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 434 (2005) 400-404
39. Sharp A., Robinson D., and Jacobs P. Age- and tissue-specific variation of X chromosome inactivation ratios in normal women. Hum Genet 107 (2000) 343-349
40. Chagnon P., Provost S., Belisle C., Bolduc V., Gingras M., and Busque L. Age-associated skewing of X-inactivation ratios of blood cells in normal females: a candidate-gene analysis approach. Exp Hematol 33 (2005) 1209-1214
41. Brown C.J., and Robinson W.P. The causes and consequences of random and non-random X chromosome inactivation in humans. Clin Genet 58 (2000) 353-363
42. Stewart J.J. The female X-inactivation mosaic in systemic lupus erythematosus. Immunol Today 19 (1998) 352-357
43. Huang Q., Parfitt A., Grennan D.M., and Manolios N. X-chromosome inactivation in monozygotic twins with systemic lupus erythematosus. Autoimmunity 26 (1997) 85-93
44. Chitnis S., Monteiro J., Glass D., Apatoff B., Salmon J., Concannon P., et al. The role of X-chromosome inactivation in female predisposition to autoimmunity. Arthritis Res 2 (2000) 399-406
45. Desai-Mehta A., Lu L., Ramsey-Goldman R., and Datta S.K. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest 97 (1996) 2063-2073
46. Lu Q., Wu A., Tesmer L., Ray D., Yousif N., and Richardson B. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J Immunol 179 (2007) 6352-6358
47. Knudsen G.P., Harbo H.F., Smestad C., Celius E.G., Akesson E., Oturai A., et al. X chromosome inactivation in females with multiple sclerosis. Eur J Neurol 14 (2007) 1392-1396
48. Miozzo M., Selmi C., Gentilin B., Grati F.R., Sirchia S., Oertelt S., et al. Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis. Hepatology 46 (2007) 456-462
49. Ozbalkan Z., Bagislar S., Kiraz S., Akyerli C.B., Ozer H.T., Yavuz S., et al. Skewed X chromosome inactivation in blood cells of women with scleroderma. Arthritis Rheum 52 (2005) 1564-1570
50. Uz E., Loubiere L.S., Gadi V.K., Ozbalkan Z., Stewart J., Nelson J.L., et al. Skewed X-chromosome inactivation in scleroderma. Clin Rev Allergy Immunol 34 (2007) 352-355
51. Brix T.H., Knudsen G.P., Kristiansen M., Kyvik K.O., Orstavik K.H., and Hegedus L. High frequency of skewed X-chromosome inactivation in females with autoimmune thyroid disease: a possible explanation for the female predisposition to thyroid autoimmunity. J Clin Endocrinol Metab 90 (2005) 5949-5953
52. Ozcelik T., Uz E., Akyerli C.B., Bagislar S., Mustafa C.A., Gursoy A., et al. Evidence from autoimmune thyroiditis of skewed X-chromosome inactivation in female predisposition to autoimmunity. Eur J Hum Genet 14 (2006) 791-797
53. Yin X., Latif R., Tomer Y., and Davies T.F. Thyroid epigenetics: X chromosome inactivation in patients with autoimmune thyroid disease. Ann N Y Acad Sci 1110 (2007) 193-200
54. Ozcelik T. X Chromosome inactivation and female predisposition to autoimmunity. Clin Rev Allergy Immunol 34 (2008) 348-351
55. Invernizzi P., Miozzo M., Battezzati P.M., Bianchi I., Grati F.R., Simoni G., et al. Frequency of monosomy X in women with primary biliary cirrhosis. Lancet 363 (2004) 533-535
56. Invernizzi P., Miozzo M., Selmi C., Persani L., Battezzati P.M., Zuin M., et al. X chromosome monosomy: a common mechanism for autoimmune diseases. J Immunol 175 (2005) 575-578
57. Invernizzi P, Miozzo M, Oertelt-Prigione S, Meroni PL, Persani L, Selmi C, et al. X monosomy in female systemic lupus erythematosus. Ann NY Acad Sci 2007;1110:84-91.
58. Milkiewicz P., and Heathcote J. Can Turner syndrome teach us about the pathogenesis of chronic cholestasis?. Hepatology 40 (2004) 1226-1228
59. Ranke M.B., and Saenger P. Turner's syndrome. Lancet 358 (2001) 309-314
60. Davis C.J., Davison R.M., Payne N.N., Rodeck C.H., and Conway G.S. Female sex preponderance for idiopathic familial premature ovarian failure suggests an X chromosome defect: opinion. Hum Reprod 15 (2000) 2418-2422
61. Dorshkind K., Montecino-Rodriguez E., and Signer R.A. The ageing immune system: is it ever too old to become young again?. Nat Rev Immunol 9 (2009) 57-62
62. Cooper G.S., and Stroehla B.C. The epidemiology of autoimmune diseases. Autoimmun Rev 2 (2003) 119-125